EPS International will merge with EPS Corporation, an EPS Holdings Group company, on September 1, 2022. The merger of these two EPS Group companies will provide enhanced synergistic full CRO services for all worldwide pharmaceutical, biotechnology, medical device companies planning to conduct clinical studies in Japan and Asia Pacific.” Please visit the EPS Corporation LinkedIn page for more information: https://lnkd.in/gyYxR8Q9